IS BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG USE IN PATIENTS WITH AUTOIMMUNE DISEASES A RISK FACTOR FOR SEVERE SARS-COV-2 INFECTION?

Detalles Bibliográficos
Autores principales: WAQAR, HAFIZA HAREEM, MAHMOOD, FATIMA, NAUTIYAL, AMIT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:
Lung Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548847/
http://dx.doi.org/10.1016/j.chest.2022.08.1547
Descripción
Sumario:

Ejemplares similares